Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 22.38
-0.60 (-2.61%)
Mar 28, 2025, 1:53 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 1.53 billion as of March 28, 2025. Its market cap has decreased by -5.64% in one year.
Market Cap
1.53B
Enterprise Value
2.20B
Revenue
171.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.38
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 1.53B, an increase of 4,868.11%. That is a compound annual growth rate of 25.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 100.22B |
| Getinge AB | 60.03B |
| Sectra AB | 47.65B |
| Camurus AB | 34.66B |
| Medicover AB | 29.34B |
| Vitrolife AB | 21.83B |
| Vimian Group AB | 21.69B |
| Elekta AB | 20.73B |